ZA9711456B - VEGF-B/receptor complex and uses thereof. - Google Patents
VEGF-B/receptor complex and uses thereof.Info
- Publication number
- ZA9711456B ZA9711456B ZA9711456A ZA9711456A ZA9711456B ZA 9711456 B ZA9711456 B ZA 9711456B ZA 9711456 A ZA9711456 A ZA 9711456A ZA 9711456 A ZA9711456 A ZA 9711456A ZA 9711456 B ZA9711456 B ZA 9711456B
- Authority
- ZA
- South Africa
- Prior art keywords
- vegf
- receptor complex
- receptor
- complex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3369796P | 1996-12-20 | 1996-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9711456B true ZA9711456B (en) | 1998-06-30 |
Family
ID=21871932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9711456A ZA9711456B (en) | 1996-12-20 | 1997-12-19 | VEGF-B/receptor complex and uses thereof. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0960334A1 (en) |
JP (1) | JP2000516478A (en) |
AU (1) | AU742779B2 (en) |
CA (1) | CA2274675A1 (en) |
WO (1) | WO1998028621A1 (en) |
ZA (1) | ZA9711456B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783953B1 (en) | 1998-12-22 | 2004-08-31 | Janssen Pharmaceutica N.V. | Vascular endothelial growth factor-X |
WO2005087808A2 (en) | 2004-03-05 | 2005-09-22 | Ludwig Institute For Cancer Research | Growth factor binding constructs materials and methods |
US20070111326A1 (en) * | 2005-11-14 | 2007-05-17 | Abbott Laboratories | Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia |
PL2548578T3 (en) | 2006-05-17 | 2014-12-31 | The Ludwig Institute For Cancer Res | Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
DK2547359T3 (en) | 2010-03-15 | 2016-06-06 | The Board Of Trustees Of The Univ Of Illionis | Inhibitors of beta integrin G-protein alpha subunit-BINDING INTERACTIONS |
WO2012087943A2 (en) | 2010-12-20 | 2012-06-28 | The Regents Of The University Of Michigan | Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction |
RU2699007C2 (en) | 2013-02-18 | 2019-09-02 | Ведженикс Пти Лимитед | Molecules which bind ligands and use thereof |
JP2016036322A (en) * | 2014-08-11 | 2016-03-22 | 日本化薬株式会社 | Chimeric protein binding to angiogenic factor |
US20220347113A1 (en) | 2019-11-07 | 2022-11-03 | The Board Of Trustees Of The University Of Illinois | Peptides and methods of treating sepsis, atherosclerosis, thrombosis, stroke, heart attack and inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5712395A (en) * | 1992-11-13 | 1998-01-27 | Yissum Research Development Corp. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
US5928939A (en) * | 1995-03-01 | 1999-07-27 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-b and dna coding therefor |
-
1997
- 1997-12-19 CA CA002274675A patent/CA2274675A1/en not_active Abandoned
- 1997-12-19 WO PCT/US1997/023533 patent/WO1998028621A1/en not_active Application Discontinuation
- 1997-12-19 AU AU56136/98A patent/AU742779B2/en not_active Ceased
- 1997-12-19 ZA ZA9711456A patent/ZA9711456B/en unknown
- 1997-12-19 JP JP10528986A patent/JP2000516478A/en active Pending
- 1997-12-19 EP EP97952553A patent/EP0960334A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU742779B2 (en) | 2002-01-10 |
EP0960334A1 (en) | 1999-12-01 |
CA2274675A1 (en) | 1998-07-02 |
WO1998028621A1 (en) | 1998-07-02 |
AU5613698A (en) | 1998-07-17 |
JP2000516478A (en) | 2000-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0003853A3 (en) | Block copolymer | |
ZA9710429B (en) | Broad-spectrumδ-endotoxins. | |
ZA978178B (en) | Composition. | |
EP0894807A4 (en) | GPIb-LIPID COMPLEX AND USES THEREOF | |
ZA976168B (en) | 3-Ureido-pyridofurans and -pyridothiophenes. | |
ZA979199B (en) | Aminothiophenecarboxamides. | |
ZA976021B (en) | Bicyclic-fused pyridines. | |
ZA977206B (en) | Arylalkanoylpyridazines. | |
ZA978304B (en) | 3-alkyl-3-phenyl-piperidines. | |
GB9608488D0 (en) | Compositions, processes and uses | |
GB9608485D0 (en) | Compositions, processes and uses | |
GB9617923D0 (en) | Novel receptor | |
ZA9711456B (en) | VEGF-B/receptor complex and uses thereof. | |
ZA975195B (en) | Human type II gonadotropin-releasing hormone receptor. | |
ZA972687B (en) | Finger-protective device. | |
ZA97572B (en) | 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines. | |
GB9608489D0 (en) | Compositions, processes and uses | |
ZA963620B (en) | (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use. | |
HK1016333A1 (en) | Kara-ok device. | |
AU3935897A (en) | B1-bradykinin receptor antagonists and use thereof | |
ZA9711047B (en) | Formulation and use. | |
ZA976022B (en) | Cycloalkano-pyridines. | |
GB9608491D0 (en) | Compositions, processes and uses | |
AU6560398A (en) | Angiogenin receptor, compositions and methods related thereto | |
ZA971466B (en) | Endothelin-receptor-antagonists. |